Welireg
Drug timelines are a Plus or Pro feature.
20 regulatory and trial events tracked for Welireg, covering 2021-08-13 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: Study of Belzutifan (MK-6482) Plus Fulvestrant for ER+/HER2- Metastatic Breast Cancer (MK-6482-029/LITESPARK-029) [Phase 2]